Our latest studies indicated that altered eIF3a expression correlates with the prognosis of non-small lung cancer23 and that eIF3a expression was associated with the response of lung cancer patients to platinum-based chemotherapy through the regulation of DNA repair pathways24. This evidence concerns the gene EIF3A and lung cancer.